{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "58468-0251",
      "generic_name": "rilzabrutinib",
      "labeler_name": "Genzyme Corporation",
      "brand_name": "WAYRILZ",
      "active_ingredients": [
        {
          "name": "RILZABRUTINIB",
          "strength": "400 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "58468-0251-5",
          "description": "2 BLISTER PACK in 1 CARTON (58468-0251-5)  / 28 TABLET, FILM COATED in 1 BLISTER PACK (58468-0251-0)",
          "marketing_start_date": "20250829",
          "sample": false
        },
        {
          "package_ndc": "58468-0251-6",
          "description": "1 BOTTLE in 1 CARTON (58468-0251-6)  / 60 TABLET, FILM COATED in 1 BOTTLE",
          "marketing_start_date": "20250829",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Genzyme Corporation"
        ],
        "rxcui": [
          "2722403",
          "2722409"
        ],
        "spl_set_id": [
          "95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175605",
          "N0000193934",
          "N0000190114",
          "N0000185503",
          "N0000190113",
          "N0000190107",
          "N0000190108",
          "N0000193845"
        ],
        "pharm_class_epc": [
          "Kinase Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Bruton's Tyrosine Kinase Inhibitors [MoA]",
          "Cytochrome P450 3A Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]",
          "Breast Cancer Resistance Protein Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]",
          "Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]",
          "Bile Salt Export Pump Inhibitors [MoA]"
        ],
        "unii": [
          "NWN58M4F5T"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "aa3b7d8a-0e0d-481b-bd36-4befaceba422",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250829",
      "product_id": "58468-0251_aa3b7d8a-0e0d-481b-bd36-4befaceba422",
      "application_number": "NDA219685",
      "brand_name_base": "WAYRILZ"
    }
  ]
}